4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Impaired mitochondria of Tregs decreases OXPHOS-derived ATP in primary immune thrombocytopenia with positive plasma pathogens detected by metagenomic sequencing

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Primary immune thrombocytopenia (ITP) is an autoimmune disease. Some ITP patients are associated with pathogen infection undetected with conventional technologies. Investigating the changes of T cells and potential metabolic mechanism are important for better understanding of ITP.

          Methods

          The study enrolled 75 newly diagnosed ITP patients. The pathogens of patients were detected by metagenomic next-generation sequencing (mNGS). Plasma lipids were measured by liquid chromatography-mass spectrometry (LC–MS). CD4 T cell and CD8 T cell were analyzed using flow cytometry. Mitochondrial reactive oxygen species (ROS) and mitochondrial membrane potential were measured by flow cytometry. Seahorse XF real-time ATP rate assay was used to investigate the change of cellular metabolism.

          Results

          Positive plasma pathogens were detected in seven ITP patients. Of them, 5 (71.4%) positive pathogen-ITP patients were no response (NR) after first-line treatment with corticosteroids. Regulatory T cells (Tregs) increased significantly in positive pathogen-ITP patients compared to negative pathogen-ITP patients and healthy controls (HC). Mitochondrial membrane potential of Th17 and Tregs were decreased in positive pathogen-ITP and negative pathogen-ITP patients, compared to HC (all p < 0.05). The overall metabolism flux of positive pathogen-ITP patients was decreased, as compared to HC ( p = 0.004), of them a higher proportion of glycolysis-derived ATP and a smaller proportion of oxidative phosphorylation (OXPHOS)-derived ATP were found in Tregs. The ATP rate index of Tregs was decreased significantly in positive pathogen-ITP patients compared to negative pathogen-ITP patients and HC ( p < 0.05).

          Conclusions

          Impaired mitochondria function of Tregs in positive pathogen-ITP patients caused a decrease of OXPHOS-derived ATP and overall metabolism flux that might be the cause of steroid resistance in ITP patients.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Molecular and cellular insights into T cell exhaustion.

          In chronic infections and cancer, T cells are exposed to persistent antigen and/or inflammatory signals. This scenario is often associated with the deterioration of T cell function: a state called 'exhaustion'. Exhausted T cells lose robust effector functions, express multiple inhibitory receptors and are defined by an altered transcriptional programme. T cell exhaustion is often associated with inefficient control of persisting infections and tumours, but revitalization of exhausted T cells can reinvigorate immunity. Here, we review recent advances that provide a clearer molecular understanding of T cell exhaustion and reveal new therapeutic targets for persisting infections and cancer.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A guide to immunometabolism for immunologists.

            In recent years a substantial number of findings have been made in the area of immunometabolism, by which we mean the changes in intracellular metabolic pathways in immune cells that alter their function. Here, we provide a brief refresher course on six of the major metabolic pathways involved (specifically, glycolysis, the tricarboxylic acid (TCA) cycle, the pentose phosphate pathway, fatty acid oxidation, fatty acid synthesis and amino acid metabolism), giving specific examples of how precise changes in the metabolites of these pathways shape the immune cell response. What is emerging is a complex interplay between metabolic reprogramming and immunity, which is providing an extra dimension to our understanding of the immune system in health and disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Fueling immunity: insights into metabolism and lymphocyte function.

              Lymphocytes face major metabolic challenges upon activation. They must meet the bioenergetic and biosynthetic demands of increased cell proliferation and also adapt to changing environmental conditions, in which nutrients and oxygen may be limiting. An emerging theme in immunology is that metabolic reprogramming and lymphocyte activation are intricately linked. However, why T cells adopt specific metabolic programs and the impact that these programs have on T cell function and, ultimately, immunological outcome remain unclear. Research on tumor cell metabolism has provided valuable insight into metabolic pathways important for cell proliferation and the influence of metabolites themselves on signal transduction and epigenetic programming. In this Review, we highlight emerging concepts regarding metabolic reprogramming in proliferating cells and discuss their potential impact on T cell fate and function.
                Bookmark

                Author and article information

                Contributors
                zhan.yanxia@zs-hospital.sh.cn
                18111210007@fudan.edu.cn
                ji.lili@zs-hospital.sh.cn
                zhang.miaomiao@zs-hospital.sh.cn
                shen.qi@zs-hospital.sh.cn
                20111270002@fudan.edu.cn
                19111210024@fudan.edu.cn
                20111210137@fudan.edu.cn
                hua_fanli@fudan.edu.cn
                qpsunlh023@126.com
                li.feng@zs-hospital.sh.cn
                h.chen@fudan.edu.cn
                yfcheng@fudan.edu.cn
                Journal
                Exp Hematol Oncol
                Exp Hematol Oncol
                Experimental Hematology & Oncology
                BioMed Central (London )
                2162-3619
                1 September 2022
                1 September 2022
                2022
                : 11
                : 48
                Affiliations
                [1 ]GRID grid.413087.9, ISNI 0000 0004 1755 3939, Department of Hematology, , Zhongshan Hospital, Fudan University, ; 180 Fenglin Rd, Shanghai, 200032 China
                [2 ]GRID grid.413087.9, ISNI 0000 0004 1755 3939, Institute of Clinical Science, , Zhongshan Hospital, Fudan University, ; Shanghai, 200032 China
                [3 ]GRID grid.508387.1, ISNI 0000 0005 0231 8677, Center for Tumor Diagnosis & Therapy, , Jinshan Hospital, Fudan University, ; Shanghai, 201508 China
                [4 ]GRID grid.8547.e, ISNI 0000 0001 0125 2443, Department of Hematology, Zhongshan Hospital Qingpu Branch, , Fudan University, ; Shanghai, 201700 China
                [5 ]GRID grid.8547.e, ISNI 0000 0001 0125 2443, Department of Thoracic Surgery, Zhongshan Hospital Xuhui Branch, , Fudan University, ; 966 Mid Huaihai Rd, Shanghai, 200031 China
                Article
                304
                10.1186/s40164-022-00304-y
                9434515
                36050760
                254f1a29-8468-48c4-af0f-06d280616787
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 15 May 2022
                : 18 August 2022
                Funding
                Funded by: National Natural Science Foundation of China
                Award ID: 81500090
                Award ID: 81878898
                Award Recipient :
                Funded by: Science and Technology Commission of Shanghai Municipality
                Award ID: 21ZR1459000
                Award Recipient :
                Funded by: Program of the Shanghai Academic/Technology Researcher leader
                Award ID: 20XD1401000
                Award Recipient :
                Funded by: Shanghai Engineering Research Center of Tumor Multi-Target Gene Diagnosis
                Award ID: 20DZ2254300
                Award Recipient :
                Funded by: Key Subject Construction Program of Shanghai Health Administrative Authority
                Award ID: ZK2019B30
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2022

                Oncology & Radiotherapy
                immune thrombocytopenia,tregs (regulatory t cells),glycolysis,oxidative phosphorylation,pathogens

                Comments

                Comment on this article